Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
37.82
-2.36 (-5.87%)
At close: Jul 28, 2026, 4:00 PM EDT
37.82
0.00 (0.00%)
After-hours: Jul 28, 2026, 4:10 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.9 billion as of July 28, 2026. Its market cap has increased by 493.18% in one year.
Market Cap
1.90B
Enterprise Value
1.95B
1-Year Change
493.18%
Ranking
Category
Stock Price
$37.82
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.90B, an increase of 245.63%. That is a compound annual growth rate of 24.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.90B | 71.33% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 2.13B |
| Sionna Therapeutics | 2.06B |
| Harmony Biosciences Holdings | 2.04B |
| Mesoblast | 2.02B |
| UroGen Pharma | 2.00B |
| Palvella Therapeutics | 1.98B |
| Aurinia Pharmaceuticals | 1.97B |
| Rapport Therapeutics | 1.95B |